Skip to Content

Dengue Tetravalent Vaccine, Live use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Dec 8, 2020.

Dengue Tetravalent Vaccine, Live Levels and Effects while Breastfeeding

Summary of Use during Lactation

Dengue vaccine is a live, attenuated vaccine indicated for children up to 16 years of age. No information is available on the clinical use of dengue vaccine during breastfeeding. However, the viruses were not detected in the milk of rats given the vaccine. If dengue vaccine is required by the mother, it is not a reason to discontinue breastfeeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Dengue Tetravalent Vaccine, Live

Drug Class

Breastfeeding

Lactation

Vaccines

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.